- Castle Biosciences to Present New Data at 2024 ASCO® Annual Meeting Highlighting Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Metastasis to the Central Nervous System to Prompt Use of Imaging Surveillance
- New Publication Shows DecisionDx®-SCC Identifies High-Risk Squamous Cell Carcinoma Patients Who Are Likely to Benefit from Adjuvant Radiation Therapy and Those Who Can Consider Deferring Treatment Based on Biological Risk of Metastasis
- Castle Biosciences to Present at the Leerink Partners Healthcare Crossroads Conference
- Castle Biosciences Expands Evidence Supporting the Performance of its TissueCypher® Barrett’s Esophagus Test in Predicting Future Development of Esophageal Cancer Through Multiple Data Presentations at DDW 2024
- Castle Biosciences’ IDgenetix® Test Receives 2024 MedTech Breakthrough Award for “Best Overall Mental Health Solution”
- Largest Prospective Study to Date Further Supports Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with DecisionDx-UM Class Result
- DecisionDx®-SCC Significantly Improves Prediction Accuracy of Metastatic Events after Mohs Surgery in New Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Tumors of the Head and Neck
- Castle Biosciences Reports First Quarter 2024 Results
- Castle Biosciences Kicks off Skin Cancer Awareness Month with a Ribbon Cutting to Celebrate the City of Friendswood’s Designation as a Sun Safe Leadership Model City by IMPACT Melanoma
- Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024
More ▼
Key statistics
On Friday, Castle Biosciences Inc (CSTL:NMQ) closed at 23.26, -10.23% below its 52-week high of 25.91, set on May 03, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 24.43 |
---|---|
High | 24.61 |
Low | 23.24 |
Bid | 19.00 |
Offer | 26.00 |
Previous close | 24.21 |
Average volume | 229.31k |
---|---|
Shares outstanding | 27.61m |
Free float | 26.77m |
P/E (TTM) | -- |
Market cap | 642.14m USD |
EPS (TTM) | -1.15 USD |
Data delayed at least 15 minutes, as of May 31 2024 21:00 BST.
More ▼